Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Granjeaud

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Cancer Immunology Research|July 8, 2025
Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast CancerStéphane Fattori, Laurent Gorvel, Marie-Sarah Rouvière, et al.
The Journal of Clinical Investigation|October 5, 2016
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressivenessJulie Leca, Sébastien Martinez, Sophie Lac, et al.
Blood Advances|May 24, 2024
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemiaAnne-Charlotte Le Floch, Florence Orlanducci, Marie-Christine Béné, et al.
Frontiers in Immunology|June 15, 2017
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid LeukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Blood Advances|July 2, 2024
Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AMLJulien M P Grenier, Céline Testut, Matthieu Bal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcomeAnne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, et al.
Cancers|January 28, 2021
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2<sup>+</sup> γδ T Cell Alterations with Lymph Node InvasionStéphane Fattori, Laurent Gorvel, Samuel Granjeaud, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Cancer Immunology Research|July 8, 2025
Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast CancerStéphane Fattori, Laurent Gorvel, Marie-Sarah Rouvière, et al.
The Journal of Clinical Investigation|October 5, 2016
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressivenessJulie Leca, Sébastien Martinez, Sophie Lac, et al.
Blood Advances|May 24, 2024
Low frequency of Vγ9Vδ2 T cells predicts poor survival in newly diagnosed acute myeloid leukemiaAnne-Charlotte Le Floch, Florence Orlanducci, Marie-Christine Béné, et al.
Frontiers in Immunology|June 15, 2017
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid LeukemiaAnne-Sophie Chretien, Cyril Fauriat, Florence Orlanducci, et al.
Blood Advances|July 2, 2024
Genetic deletion of JAM-C in preleukemic cells rewires leukemic stem cell gene expression program in AMLJulien M P Grenier, Céline Testut, Matthieu Bal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcomeAnne-Sophie Chretien, Raynier Devillier, Samuel Granjeaud, et al.
Cancers|January 28, 2021
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2<sup>+</sup> γδ T Cell Alterations with Lymph Node InvasionStéphane Fattori, Laurent Gorvel, Samuel Granjeaud, et al.
Pageof 7